Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
Tamara P. Makarova,
Khakim M. Vakhitov,
Dina R. Sabirova,
Dinara I. Sadykova,
Liliya R. Khusnutdinova,
Natalya N. Firsova,
Anna A. Kucheryavaya https://doi.org/10.15690/vsp.v19i3.2117
Abstract
Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tissue disease may evolve into other systemic diseases over time. Description of any cases of mixed connective tissue disease and its evolution in Russian patients has not been published previously.
Clinical Case Description. The results of observations of the child with clinical and immunological signs of the mixed connective tissue disease followed by the progression of systemic scleroderma symptoms and development of Sjogren's syndrome in the short period of time are presented in the article. Improvement (such as pain attenuation, increase in volume of movements in affected joints, decrease of Raynaud syndrome manifestations duration) was observed on treatment (methotrexate 10 mg/week with subsequent addition of prednisolone 0.75 mg/kg/day).
Conclusion. Timely diagnostics of clinical signs of the systemic diseases debut is crucial for correct patient routing and for achieving of disease improvement.
Keywords
children,
mixed connective tissue disease,
Sharp syndrome,
overlap syndrome,
Raynaud syndrome,
arthritis
Supporting agencies: Not specified.
About the Authors
Tamara P. Makarova
Kazan State Medical University
Russian Federation
Kazan
Disclosure of interest:
Russian Federation
Kazan
Disclosure of interest:
Not declared.
Khakim M. Vakhitov
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Dina R. Sabirova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Dinara I. Sadykova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Liliya R. Khusnutdinova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Natalya N. Firsova
Children’s Republican Clinical Hospital
Russian Federation
Kazan
Russian Federation
Kazan
Anna A. Kucheryavaya
Children’s Republican Clinical Hospital
Russian Federation
Kazan
Russian Federation
Kazan
References
1. Alekperov RT. Mixed connective tissue disease, undifferentiated connective tissue disease and overlap syndromes. Almanac of Clinical Medicine. 2019;47(5):435–444. (In Russ). doi: 10.18786/2072-0505-2019-47-022.
2. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med. 1972;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2.
3. Petty R, Laxer R, Lindsley C, Wedderburn L. Mixed Connective Tissue Disease. In: Textbook of Pediatric Rheumatology. 7th ed. Elsevier; 2015. pp. 418–426.
4. Swart JF, Wulffraat NM. Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J. 2008; 10:650–652.
5. Cappelli S, Bellando Randone S, Martinovic D, et al. “To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity. Semin Arthritis Rheum. 2012;41(4):589–598. doi: 10.1016/j.semarthrit.2011.07.010.
6. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold video capillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27(1):155–160.
7. Chojnowski MM, Felis-Giemza A, Olesinska M. Capillaroscopy — a role in modern rheumatology. Reumatologia. 2016;54(2):67–72. doi:10.5114/reum.2016.60215.
8. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp G, eds. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier; 1987. pp. 41–47.
9. Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40(7):1134–1142. doi: 10,3899/jrheum.121272.
10. Mier RJ, Shishov M, Higgins GC, et al. Pediatric-onset mixed connective tissue disease. Rheum Dis Clin North Am. 2005; 31(3):483–496. doi:10.1016/j.rdc.2005.04.002.
11. Klinicheskie rekomendatsii «Sistemnyi skleroz». Moscow: Soyuz pediatrov Rossii; 2017. (In Russ). Доступно по: https://kiberis.ru/?p=50526. Ссылка активна на 22.06.2020.
12. Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier; 1987. pp. 33–40.
13. Kahn MF, Bourgeois P, Aeschlimann A, de Truchis P. Mixed connective tissue disease after exposure to polyvinyl chloride. J Rheumatol. 1989;16(4):533–535.
14. John KJ, Sadiq M, George T, et al. Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria. Int J Rheumatol. 2020;2020:9692030. doi:10.1155/2020/9692030.
15. Williamson MA, Snyder LM, Wallach JB. Wallach’s Interpretation of Diagnostic Tests. Philadelphia: Wolters Kluwer/ Lippincott Williams & Wilkins; 2011. p. 1035.
16. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undiffe rentiated, or both? J Rheumatol. 2005;32(2):213–215.
17. Kubo S, Smith V, Cutolo M, Tanaka Y. The role of nailfold videocapillaroscopy in patients with systemic sclerosis. Immunol Med. 2018;41(3):113–119. doi: 10.1080/25785826.2018.1531189.
18. Kaleda MI, Nikishina IP, Latypova AN. Sjogren’s syndrome with juvenile onset. Therapeutic Archive. 2019; 91(5):54–60. (In Russ). doi: 10.26442/00403660.2019.05.000189.
19. Yokogawa N, Lieberman SM, Sherry DD, Vivino FB. Features of childhood Sjogren’s syndrome in comparison to adult Sjogren’s syndrome: considerations in establishing child-specific diagnostic criteria. Clin Exp Rheumatol. 2016;34(2):343-351.
Review
For citations:
Makarova T.P., Vakhitov Kh.M., Sabirova D.R., Sadykova D.I., Khusnutdinova L.R., Firsova N.N., Kucheryavaya A.A. Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case. Current Pediatrics. 2020;19(3):214-219. (In Russ.) https://doi.org/10.15690/vsp.v19i3.2117
Views:
1947
Email this article 
